BlackBerry and NantHealth, a health analytics company, said they will combine to launch a clinical genome browser on the Passport.
The browser, which will be demonstrated at the Consumer Electronics Show in January, highlights how BlackBerry is targeting regulated verticals.
Also see: BlackBerry's bounce-back plan: Turning old rivals into new allies | BlackBerry's CEO speaks frankly about comeback plans with new enterprise platform | Buying enterprise mobility management: How important is independence? | BlackBerry makes top 10 enterprise mobility management cut, says Forrester | BlackBerry's Passport: An enterprise muscle car?
NantHealth provides cloud-based analytics to hospitals. The NantOmics Cancer Genome Browser will provide interactive reporting for oncologists on the Passport. The browser is the first in a series of platforms that BlackBerry and NantHealth are planning.
BlackBerry is pitching the Passport's size, screen and security as advantages for healthcare. For instance, the NantOmics browser is encrypted and can be deployed in a HIPAA environment. In addition, BlackBerry is also pitching its enterprise mobility management tools to hospital technology admins.
Patrick Soon Shiong, M.D., medical director of NantHealth, is leading the charge in using DNA, RNA and proteomics to fight cancer. NantHealth's labs will be operational in early 2015.
Shiong was profiled on 60 Minutes Sunday.